Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ample Organics is a leading provider of cannabis management software, offering a comprehensive seed-to-sale platform designed for the highly regulated cannabis industry. Founded in 2014 and based in Toronto, the company's technology facilitates compliance, inventory tracking, and reporting for licensed producers, particularly within the Canadian market. The platform integrates various aspects of the cannabis supply chain, including cultivation, processing, and patient registration for medical use. Ample Organics was acquired by Akerna Corp in 2020 and subsequently became part of Alleaves in 2023, continuing to serve as a critical infrastructure provider for cannabis businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ample Organics.